August 1, 2017 | Silenseed, an Israeli, clinical-stage bio-pharmaceutical company that develops cancer therapies, is raising $10 million. Founded in 1999 by Amotz Shemi, the company is planning to use the money to fund the second phase of a trial, which was recently approved by the FDA, to develop a pancreatic cancer treatment. Silenseed uses […]

For the founders of any startup, the defining moment of success is to have their company go public on NASDAQ. In 2014, six Israeli companies are hoping to live out this dream, raising an aggregate total of $883 million. It looks like going public is the new exit.